PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-171

  1. 105 Posts.
    lightbulb Created with Sketch. 3
    Donna verbally mentioned in the preso that they used MRI as they were able to measure more accurately than xray.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.